TMDX250117P90000
- 11.30
- -18.26-61.77%
TransMedics Newsroom
Why Transmedics Plunged in December
Oppenheimer Maintains TransMedics(TMDX.US) With Buy Rating, Maintains Target Price $125
Piper Sandler Maintains TransMedics(TMDX.US) With Buy Rating, Maintains Target Price $90
Piper Sandler Sticks to Its Buy Rating for TransMedics Group (TMDX)
TCMD Stock Rises 20% in Three Months: Should You Buy, Hold or Sell?
ABAT, KULR and GME Among Trending Stocks in the Slow Holiday-shortened Week
10 Health Care Stocks With Whale Alerts In Today's Session
Those Who Invested in TransMedics Group (NASDAQ:TMDX) Five Years Ago Are up 236%
TransMedics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Looking Into TransMedics Gr's Recent Short Interest
$100 Invested In TransMedics Gr 5 Years Ago Would Be Worth This Much Today
J.P. Morgan Downgrades TransMedics(TMDX.US) to Hold Rating, Cuts Target Price to $75
TransMedics Downgraded to Neutral From Overweight at JPMorgan
Express News | Transmedics Group Inc : JP Morgan Cuts to Neutral From Overweight; Cuts Target Price to $75 From $116
TransMedics Stock Plunges 57.5% in Three Months: What's Next?
Express News | Transmedics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Morgan Stanley Maintains TransMedics(TMDX.US) With Hold Rating, Maintains Target Price $80
Morgan Stanley Maintains TransMedics(TMDX.US) With Hold Rating, Cuts Target Price to $80
TransMedics Group: Balancing Long-term Promise With Short-term Uncertainty – Hold Rating Maintained